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Hepatic angiomyolipoma is a rare primary liver tumor, with a radiographic appearance very similar to hepatocellular carcinoma.
We present the case of a noncirrhotic patient with a liver tumor suspicious for HCC by imaging features. Liver biopsy demonstrated
angiomyolipoma, and the patient successfully underwent a laparoscopic liver resection.
1. Introduction
Hepatic angiomyolipoma (AML) is a rare primary liver
tumor, described only by small case series. Most cases occur
in middle-aged women, who either are asymptomatic or
describe vague abdominal pain. AMLs are tumors of mixed
mesenchymal origin and predominantly occur in the kidney.
Radiographically, hepatic AML can be difficult to differ-
entiate from other liver tumors, particularly hepatocellular
carcinoma (HCC), as they commonly appear as well-defined
lesions with CT arterial phase enhancement and “washout”
in the portal and delayed phases. Imaging features are not
specific and can lead to a misdiagnosis of HCC if pathologic
confirmation is not obtained [1]. The gold standard for
the diagnosis of hepatic AML is histologic examination
and immunohistochemical staining from biopsy or surgical
specimen.
We present a case of epithelioid hepatic AML diagnosed
preoperatively by biopsy and successfully laparoscopically
resected.
2. Case Report
A54-year-oldCaucasian femalewith a history of cholecystec-
tomy, obesity, and hypertension presented to the Emergency
Department with acute onset right upper abdominal pain.
Basic laboratories including liver function tests, complete
blood count, and basic metabolic panel were unrevealing.
Outpatient workup revealed normal AFP, CA19-9, and
CEA levels and negative hepatitis serologies. Ultrasound
demonstrated a 2.3 cm, low-density mass in the left liver lobe.
MRI showed a 3.4 cm mass with arterial phase enhancement
and contrast washout in delayed sequences (Figure 1). By
imaging, a diagnosis of HCC was suspected. However, as
she did not have cirrhosis or other risk factors for HCC, she
underwent percutaneous liver biopsy andwas diagnosedwith
epithelioid AML.
Thepatient underwent laparoscopic hand-assisted left lat-
eral hepatic segmentectomy. Our surgical approach included
three trocar sites and a small midline hand port. Resection
was completed using a combination of Ligasure and Cavitron
Ultrasonic Surgical Aspirator (CUSA). One Jackson-Pratt
drain was left at the cut edge of the liver.
Pathologic gross examination revealed a 3.0 x 2.5 x 2.0 cm
mass, well-demarcated from adjacent hepatic parenchyma
(Figure 2). On microscopy, an admixture of haphazardly
arranged mature adipocytes, smooth muscle fascicles, and
thick-walled vessels was seen, whichwas positive forHMB45,
MelanA, MITF, and smooth muscle actin and negative for
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Figure 1:MRI. FIESTA (right) and T1-weighted images (left) revealed a 3.1 x 3.4 x 2 cm mass in the left lateral lobe of the liver. The lesion is
hypervascular with washout of contrast on delayed post-contrast enhanced sequences.
Figure 2: Gross specimen. On gross examination of the liver specimen, the cut surface of liver showed a well-demarcated, glistening, tan-
yellow, lobular mass, measuring 3.0 x 2.5 x 2.0 cm. Final surgical pathology confirmed the diagnosis of epithelioid angiomyolipoma with no
evidence of malignancy and 2.2 cm surgical margins.
pan-cytokeratin, HepPar1, and S100, confirming the diagno-
sis (Figure 3). She was discharged after an uneventful hospital
course.
The patient was seen in follow-up one year after her
tumor resection. She was doing well and had fully returned
to her presurgical level of function. 4-phase liver CT done at
that time demonstrated no tumor recurrence or evidence of
abdominal metastasis. LFTs were all within normal range.
3. Discussion
Hepatic AML typically presents as an incidentally found liver
mass or in patients with vague abdominal discomfort, as in
our case. Rarely are these tumors large enough to lead to
presentation from mass effect, palpation, or rupture, though
this has all been reported [2].There is a known link associated
with tuberous sclerosis of 5-15%, but this link is stronger
in renal AML [3]. Hepatic epithelioid AML is rare and
routinely misdiagnosed. One report identified 292 patients
with hepatic AML, only 12 of which were epithelioid subtype
[4].
On contrast-enhanced imaging, both hepatic AML and
HCC appear hyperenhanced in the arterial phase with early
washout times [5]. Several reports reveal rates of misdiagno-
sis of hepatic AML as HCC ranging from 25 to 80% [1, 5–
7]. Because radiologic features make hepatic AML difficult
to distinguish from HCC, the diagnosis of hepatic AML
relies on immunohistochemical staining; HMB45 and SMA
are positive, and Hep Par1 and S100 are negative [8]. On
histology, smooth muscle presence with variable distribution
of epithelial cells, adipose cells, and blood vessels is seen.
Misdiagnosis as HCC has serious clinical and psycho-
logical implications for patients. Biopsies are not routinely
performed once a radiographic diagnosis of HCC is made.
Traditional treatment for HCC in a noncirrhotic patient is
liver resection. However, liver transplantation is evolving as
the standard of care for small HCCs due to simultaneous
survival benefit and reduction in disease recurrence [9]. The
diagnosis of HCC in our otherwise healthy patient was sus-
picious in the absence of other risk factors; therefore image-
guided biopsy was performed to confirm her diagnosis.
Preoperative biopsy providing accurate diagnosis in this case
was useful as it allowed for comprehensive patient education
and surgical planning. With liver transplant becoming an
option for HCCmanagement in many patients, misdiagnosis
by imaging alone could have led to unnecessary and invasive
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Figure 3:Histopathologic features of epithelioid angiomyolipoma. (a)Well-circumscribedmasswith adjacent,mildly steatotic liver parenchyma
(H&E; 20x). (b) The tumor is composed of eosinophilic cells, mature adipocytes, and thick walled vessels (center) (H&E; 100x). (c) The
smooth muscle component includes a mixture of large epithelioid cells with abundant eosinophilic cytoplasm and prominent nucleoli, with
interspersed smaller epithelioid cells and spindle cells (H&E; 400x). Immunohistochemistry performedon the biopsy of this lesion forHMB45
(200x) (d) and Smooth Muscle Actin (200x) (e) showed patchy, strong positivity in the lesional cells.
procedures. Due to the risk of malignant transformation or
rupture of hepatic AML [10], resection is typically recom-
mended. In select cases, a nonoperative approach with close
surveillance is appropriate as mortality remains low at 0.8%
[4].
Accurate preoperative diagnosis as AML allowed the
patient and surgeon to come to an informed decision and
to undergo the appropriate treatment of minimally invasive
resection. Damaskos et al. reported the first laparoscopic
resection of hepatic AML in 2017, and our case further
demonstrates the safety and utility of this approach [11]. In
the absence of metastatic lesions, most reports support good
surgical outcomes and long-term survival for hepatic AML
patients [2, 3].
We encourage clinicians to have a high index of suspicion
of misdiagnosis of HCC in noncirrhotic patients without
other HCC risk factors and to employ preoperative biopsy
to confirm diagnosis in these cases. A correct diagnosis
is crucial to tailor appropriate tumor management. HCC
warrants excision in noncirrhotic patients and, increasingly,
referral for transplant evaluation; hepatic AML can be treated
with a laparoscopic resection as a safe, novel alternative to
open surgery or clinical observation.
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